Université de Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.
Methods Mol Biol. 2023;2618:173-186. doi: 10.1007/978-1-0716-2938-3_13.
Dendritic cells (DCs) are antigen-presenting cells (APCs) that shape innate and adaptive immunity. There are multiple subsets of DCs distinguished according to their phenotype and functional specialization. DCs are present in lymphoid organs and across multiple tissues. However, their frequency and numbers at these sites are very low making their functional study difficult. Multiple protocols have been developed to generate DCs in vitro from bone marrow progenitors, but they do not fully recapitulate DC complexity found in vivo. Therefore, directly amplifying endogenous DCs in vivo appears as an option to overcome this specific caveat. In this chapter, we describe a protocol to amplify murine DCs in vivo by the injection of a B16 melanoma cell line expressing the trophic factor FMS-like tyrosine kinase 3 ligand (Flt3L). We have also compared two methods of magnetic sorting of amplified DCs, both giving high yields of total murine DCs, but different representation of the main DC subsets found in vivo.
树突状细胞 (DCs) 是一种抗原呈递细胞 (APC),能够调节先天免疫和适应性免疫。根据其表型和功能特点,DC 可分为多个亚群。DC 存在于淋巴器官和多种组织中。然而,由于其在这些部位的频率和数量非常低,因此其功能研究较为困难。目前已经开发了多种从骨髓祖细胞体外生成 DC 的方案,但这些方案并不能完全重现体内 DC 的复杂性。因此,直接在体内扩增内源性 DC 似乎是克服这一特定局限性的一种选择。在本章中,我们描述了一种通过注射表达营养因子 FMS 样酪氨酸激酶 3 配体 (Flt3L) 的 B16 黑色素瘤细胞系在体内扩增鼠 DC 的方案。我们还比较了两种体内扩增 DC 的磁分选方法,这两种方法都能获得大量的总鼠 DC,但体内主要 DC 亚群的代表性不同。